Abstract 2623: Common genetic variants associated with breast cancer risk used in the Athena study to enhance models identifying women for breast cancer chemoprevention

Background: The U.S. Preventive Services Task Force recommends that women with a >3% five-year risk of developing breast cancer consider taking selective estrogen receptor modifiers (SERMs) or aromatase inhibitors (AIs) to reduce their risk. Polygenic risk score (PRS), calculated by adding the in...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cancer research (Chicago, Ill.) Ill.), 2016-07, Vol.76 (14_Supplement), p.2623-2623
Hauptverfasser:	Theiner, Sarah, Sawyer, Sarah D., Kendall, Paige, Perry, Alexandra S., Wolf, Denise, Huntsman, Scott, Pan, Bo, Tice, Jeffery A., Pearce, David A., Cink, Thomas, Esserman, Laura, Ziv, Elad, van ‘t Veer, Laura
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!